Comparative efficacy and safety of nebivolol in hypertension: a systematic review and network meta-analysis
It is established that nebivolol delivers significant SBP and DBP lowering compared with placebo, whilst outperforming traditional beta-blockers in overall blood pressure normalisation, reinforces nebivolol as an optimal therapeutic choice for managing hypertension across diverse patient groups.